StockData
Ceribell, Inc. logo

Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30140% above fair value
$25.97−0.45 (-1.70%)

Close on Nov 17, 2026Market cap $996.68MP/E –Yield –

Ceribell operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Ceribell's operating cash flow for the twelve months ending Jun 30, 2026 was -$54.03M. For fiscal 2025 it was -$40.81M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$40.81M–
FY2024Dec 31, 2024-$35.04M–
FY2023Dec 31, 2023-$29.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.86M–
Q1 FY2026Mar 31, 2026-$19.30M–
Q4 FY2025Dec 31, 2025-$10.77M–
Q3 FY2025Sep 30, 2025-$11.10M–
Q2 FY2025Jun 30, 2025-$7.53M–
Q1 FY2025Mar 31, 2025-$11.40M–
Q4 FY2024Dec 31, 2024-$9.98M–
Q3 FY2024Sep 30, 2024-$8.54M–
Q2 FY2024Jun 30, 2024-$6.98M–
Q1 FY2024Mar 31, 2024-$9.55M–
Q4 FY2023Dec 31, 2023-$6.68M–

More Ceribell figures

See a number that looks wrong?